LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2021$9,000
-18.2%
94
+20.5%
0.00%
Q4 2020$11,000780.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2021
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$4,658,0002.63%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,364,434$84,745,0001.21%
CAPITAL INTERNATIONAL LTD /CA/ 259,700$16,130,0001.07%
Aureus Asset Management, LLC 65,670$4,079,0000.69%
Capital International Sarl 124,320$7,722,0000.67%
CAPITAL GUARDIAN TRUST CO 512,430$31,827,0000.58%
ROCKEFELLER FINANCIAL SERVICES INC 408,379$25,365,0000.50%
Rock Springs Capital Management LP 160,500$9,969,0000.50%
Hood River Capital Management LLC 112,296$6,975,0000.48%
Capital International, Inc./CA/ 52,700$3,273,0000.47%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders